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Abstract
In the mammalian retina, sparse amacrine cells contain somatostatin-14 (SRIF) which acts at multiple levels of neuronal circuitry
through distinct SRIF receptors (sst1–5). Among them, the sst1 receptor has been localised to SRIF-containing amacrine cells in the
rat and rabbit retina. Little is known about sst1 receptor localisation and function in the mouse retina.
We have addressed this question in the retina of mice with deletion of sst1 receptors (sst1 KO mice). In the retina of wild type
(WT) mice, sst1 receptors are localised to SRIF-containing amacrine cells, whereas in the retina of sst1 KO mice, sst1 receptors are
absent. sst1 receptor loss causes a significant increase in retinal levels of SRIF, whereas it does not affect SRIF messenger RNA
indicating that sst1 receptors play a role in limiting retinal SRIF at the post-transcriptional level. As another consequence of sst1
receptor loss, levels of expression of sst2 receptors are significantly higher than in control retinas.
Together, these findings provide the first demonstration of prominent compensatory regulation in the mouse retina as a conse-
quence of a distinct SRIF receptor deletion. The fact that in the absence of the sst1 receptor, retinal SRIF increases in concomitance
with an increase in sst2 receptors suggests that SRIF may regulate sst2 receptor expression and that this regulatory process is
controlled upstream by the sst1 receptor. This finding can be important in the design of drugs affecting SRIF function, not only in
the retina, but also elsewhere in the brain.
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1. Introduction
Somatostatin-14 (somatotropin release-inhibiting fac-
tor, SRIF) is a regulatory peptide produced throughout
the central nervous system and in most major peripheral
organs. It exerts its functions through the activation of
distinct G-protein-coupled SRIF subtype receptors desig-
nated sst1–5 (Barnett, 2003, for review).
SRIF and its receptors are found in the retina. In parti-
cular, sparse-occurring SRIF-immunoreactive neurons
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are present in the innermost inner nuclear layer (INL)
and in the ganglion cell layer (GCL) of the mammalian
retina (Bagnoli et al., 2003, for review). Those in the
INL have been identified as amacrine cells, whereas
those in the GCL are either displaced amacrine or gang-
lion cells. In the mouse retina, SRIF immunoreactivity
(IR) has been recently localised to sparse-occurring
amacrine cells present both in the proximal INL of the
entire retina and in the GCL of the ventral retina
(Cristiani et al., 2002).
In spite of the low density of SRIF-containing somata,
dense SRIF-positive processes are widely distributed to
distinct laminae of the inner plexiform layer (IPL) of the
entire retina, thus suggesting that SRIF may act at mul-
tiple levels of retinal circuitry (Bagnoli et al., 2003, for
